Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35057983)
Watch
English
Adoptive cell therapy for patients with melanoma
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
title
Adoptive cell therapy for patients with melanoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
author name string
Mark E Dudley
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
publication date
15 June 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
published in
Journal of Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
volume
2
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
page(s)
360-362
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
cites work
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Adoptive cell therapy: genetic modification to redirect effector cell specificity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Adoptive T cell therapy of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119404
retrieved
8 July 2018
Identifiers
DOI
10.7150/JCA.2.360
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
PMCID
3119404
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
PubMed ID
21716716
1 reference
stated in
Europe PubMed Central
PubMed ID
21716716
retrieved
6 August 2017
ResearchGate publication ID
51455284
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
